ASI’s Kremerman Fund
The Kremerman Fund, established by ASI, is an internal fund devoted to promoting applied research at Ariel University. The task is to bring research to an advanced stage in order to improve its chances to be commercialized
Research projects managed by the fund receive pre-seed financing and are provided with scientific, marketing and business support throughout the entire development period.
During the research period, the fund closely monitors the scientific progress and future marketing directions in order to steer the research towards future market needs and maximize the intellectual property value.
The Israel Innovation Authority (IIA)
IIA programs are intended to provide a competitive position for Israel’s industry with regard to state of the art technologies of worldwide interest. The new technologies are to be developed in a cooperative venture between the industry and leading academic scientific research in the area, and will provide the basis for new high-tech products and processes.
The IIA offers for a number of paths for cooperation:
This program supports early stage applied academic research. The program supports research with a potential to become an industrial product in later stage. The objective is to promote the research to a point where it is ready for a cooperative venture with a commercial partner. No company cooperation or incubator are required in this program. Proposals should be submitted three times a year. The maximal financial support could be up to 440,000 NIS per year for up to 2 years, and in special pharma cases a 3rd year could be approved.
This program supports applied academic research that has drawn business interest but not yet directed to a specific product. The objective is to advance the research to a point where it is ready for a cooperative venture with a commercial partner. A minimal requirement of this program is for a company or incubator to invest 10% of the development costs, complementing the 90% grant given by the government. The maximal financial support could be up to 550,000 NIS per year for up to 2 years, and in special pharma cases a 3rd year could be approved.
For additional information and forms please visit הכוונת ידע אקדמי
The incentive program encourages the transfer of technological knowledge accumulated in academia for the use of industry, by creating collaborations between Israeli companies and academic research groups. These collaborations expose industrial companies to the research achievements relevant to their activities and assist research groups in transforming academic developments into commercial applications.
For additional information and forms please visit מסלול מגנטון